Johnson RJ - Search Results

1

A role for uric acid in the progression of renal disease.

Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson RJ. Kang DH, et al. Among authors: johnson rj. J Am Soc Nephrol. 2002 Dec;13(12):2888-97. doi: 10.1097/01.asn.0000034910.58454.fd. J Am Soc Nephrol. 2002. PMID: 12444207

2

Role of platelet-derived growth factor in glomerular disease.

Johnson RJ, Floege J, Couser WG, Alpers CE. Johnson RJ, et al. J Am Soc Nephrol. 1993 Aug;4(2):119-28. doi: 10.1681/ASN.V42119. J Am Soc Nephrol. 1993. PMID: 8311852

3

SPARC is expressed in renal interstitial fibrosis and in renal vascular injury.

Pichler RH, Hugo C, Shankland SJ, Reed MJ, Bassuk JA, Andoh TF, Lombardi DM, Schwartz SM, Bennett WM, Alpers CE, Sage EH, Johnson RJ, Couser WG. Pichler RH, et al. Among authors: johnson rj. Kidney Int. 1996 Dec;50(6):1978-89. doi: 10.1038/ki.1996.520. Kidney Int. 1996. PMID: 8943481 Free article.

4

Hypothesis: the role of acquired tubulointerstitial disease in the pathogenesis of salt-dependent hypertension.

Johnson RJ, Schreiner GF. Johnson RJ, et al. Kidney Int. 1997 Nov;52(5):1169-79. doi: 10.1038/ki.1997.442. Kidney Int. 1997. PMID: 9350640 Free article. Review.

5

Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia.

Thomas SE, Anderson S, Gordon KL, Oyama TT, Shankland SJ, Johnson RJ. Thomas SE, et al. Among authors: johnson rj. J Am Soc Nephrol. 1998 Feb;9(2):231-42. doi: 10.1681/ASN.V92231. J Am Soc Nephrol. 1998. PMID: 9527399

6

Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy.

Kim YG, Suga SI, Kang DH, Jefferson JA, Mazzali M, Gordon KL, Matsui K, Breiteneder-Geleff S, Shankland SJ, Hughes J, Kerjaschki D, Schreiner GF, Johnson RJ. Kim YG, et al. Among authors: johnson rj. Kidney Int. 2000 Dec;58(6):2390-9. doi: 10.1046/j.1523-1755.2000.00422.x. Kidney Int. 2000. PMID: 11115072 Free article.

7

Involvement of macrophage migration inhibitory factor (MIF) in experimental uric acid nephropathy.

Kim YG, Huang XR, Suga S, Mazzali M, Tang D, Metz C, Bucala R, Kivlighn S, Johnson RJ, Lan HY. Kim YG, et al. Among authors: johnson rj. Mol Med. 2000 Oct;6(10):837-48. Mol Med. 2000. PMID: 11126199 Free PMC article.

8

Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease.

Kang DH, Anderson S, Kim YG, Mazzalli M, Suga S, Jefferson JA, Gordon KL, Oyama TT, Hughes J, Hugo C, Kerjaschki D, Schreiner GF, Johnson RJ. Kang DH, et al. Among authors: johnson rj. Am J Kidney Dis. 2001 Mar;37(3):601-11. doi: 10.1053/ajkd.2001.22087. Am J Kidney Dis. 2001. PMID: 11228186

9

Post-cyclosporine-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor.

Kang DH, Kim YG, Andoh TF, Gordon KL, Suga S, Mazzali M, Jefferson JA, Hughes J, Bennett W, Schreiner GF, Johnson RJ. Kang DH, et al. Among authors: johnson rj. Am J Physiol Renal Physiol. 2001 Apr;280(4):F727-36. doi: 10.1152/ajprenal.2001.280.4.F727. Am J Physiol Renal Physiol. 2001. PMID: 11249864 Free article.

10

Hyperuricemia exacerbates chronic cyclosporine nephropathy.

Mazzali M, Kim YG, Suga S, Gordon KL, Kang DH, Jefferson JA, Hughes J, Kivlighn SD, Lan HY, Johnson RJ. Mazzali M, et al. Among authors: johnson rj. Transplantation. 2001 Apr 15;71(7):900-5. doi: 10.1097/00007890-200104150-00014. Transplantation. 2001. PMID: 11349724

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,482 results

Search Page

Filters